Samsung Pharm (001360) Stock Outlook 2026: A Korean OTC Brand Moat Unrelated to Samsung Group
Samsung Pharm (001360) 2026 stock outlook for international investors: why this KOSPI-listed OTC drugmaker has no ownership link to Samsung Electronics, its Kkasmyeongsu and Woohwangchengsimwon brand moat, the Gemvax & KAEL cross-shareholding, and governance risk.